Showing 21-30 of 108 results for "".
When I Grow Up
https://modernaesthetics.com/ma-issues-index/2017-jan-feb/when-i-grow-up/34311/Exploring opportunities beyond traditional patient care. Pros and cons from those on the front-line.Skincare Recommendations for Men (And Women): Tips From Formulator
https://modernaesthetics.com/ma-issues-index/2014-july-aug/skincare-recommedations-for-men-and-women-tips-from-formulator/34616/The dermatologist behind a new line of accessible OTC skincare products offers reminders on meeting patients' needs.Emepelle for Estrogen Deficient Skin: Breakthrough For An Unmet Need
https://modernaesthetics.com/ma-supplements/2020-may-june-insert4/emepelle-for-estrogen-deficient-skin-breakthrough-for-an-unmet-need/34912/Emepelle with MEP Technology® is the only topical product line specifically designed and formulated to address the root cause of Estrogen Deficient Skin (EDS) non-hormonally.MATV NEWS: Genesis: Innovations in Aesthetic Regenerative Medicine Registration Opens And More
https://modernaesthetics.com/series/matv-news/matv-news-genesis-innovations-in-aesthetic-regenerative-medicine-registration-opens-and-more/33874/In this week's episode of MATV News, an update on the 2025 Genesis: Innovations in Aesthetic Regenerative Medicine Meeting; the FDA approves a new neurotoxin for the glabellar lines; Closing the health care gender gap; and Martha Stewart was the keystone speaker for 2025 AAD Annual Meeting.MATV News: Dr. Shino Bay Aguilera on Importance of Genesis Meeting, Allergan Aesthetics Announces Faculty for AMI Training Centers, and More
https://modernaesthetics.com/series/matv-news/matv-news-dr-shino-bay-aguilera-on-importance-of-genesis-meeting-allergan-aesthetics-announces-faculty-for-ami-training-centers-and-more/36210/In the latest episode of MATV News, Dr. Shino Bay Aguilera addresses the importance of the Genesis meeting for advancing regenerative medicine education; Allergan Aesthetics announces faculty for its new AMI Training Centers; and a Swiss skincare line known for its HA fillers is now available to patMATV News: ASDS Board; Allergan Aesthetics Expands Filler Portfolio; Sciton Gives Back; Breast Surgery Benefits
https://modernaesthetics.com/series/matv-news/matv-news-asds-board-allergan-aesthetics-expands-filler-portfolio-sciton-gives-back-breast-surgery-benefits/33591/The American Society for Dermatologic Surgery names new board at annual meeting, Sciton hosts a digital summit and gives back, Allergan Aesthetics expands its filler portfolio with the acquisition of Luminera line, and a new study shows mental health benefits of breast surgery for patients with seveMATV News: Revance to Bring Teoxane Fillers to US; Allergan Introduces Allē More
https://modernaesthetics.com/series/matv-news/matv-news-revance-to-bring-teoxane-fillers-to-us-allergan-introduces-alle-more/33521/Revance enters an exclusive distribution deal with Teoxane to bring RHA line of fillers to US Market, Allergan revamps its customer loyalty rewards program, and findings of a new study may indicate what’s driving increases in body contouring procedures.MATV News Extra: Daxxify Q&A with Dr. Jeffrey Dover
https://modernaesthetics.com/series/matv-news/matv-news-extra-daxxify-qa-with-dr-jeffrey-dover/33704/The FDA has approved Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) for injection for the temporary improvement of moderate to severe glabellar lines in adults. Dermatologists and clinical trial investigator Jeffrey Dover, MD sat down with MATV News to share insights into the SAKURA PhaseMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromMATV News: Valeant Sells Obagi; Aesthetic Trends Around the Globe
https://modernaesthetics.com/series/matv-news/matv-news-valeant-sells-obagi-aesthetic-trends-around-the-globe/33323/Valeant agrees to sell its Obagi Medical Products business, Syneron Candela is now a private company, and Allergan acquired the Reginica Advanced Rejuvenation System line. Also, coverage of the latest trends in aesthetics, according to new statistics from the International Society of Aesthetic Plast